Results 71 to 80 of about 26,737 (201)
Infection and Drug Resistance, 2020 Jie Shi, Ruyue Su, Danwei Zheng, Yankun Zhu, Xiaoguang Ma, Shaohua Wang, Hui Li, Dingyong Sun Henan Province Center for Disease Control and Prevention, Zhengzhou, Henan Province, People’s Republic of ChinaCorrespondence: Jie Shi; Dingyong Sun Tel ...
Shi J +7 more
doaj
Immunity, Inflammation and Disease, Volume 14, Issue 9, September 2026.ABSTRACT Background Anti‐tuberculosis drug‐induced liver injury (ATDILI) is one of the most prevalent and serious adverse reactions during anti‐tuberculosis treatment and can potentially lead to liver failure or mortality. This study aims to investigate whether genetic variants in the N‐acetyltransferase 2 gene (NAT2) and the HLA‐DOA gene (HLA‐DOA) are
Zhenzhen Zhao +6 more
wiley +1 more source
Pyrazinamide is a potent sterilising agent that shortens the treatment duration needed to cure tuberculosis. It is synergistic with novel and existing drugs for tuberculosis.
core
Pyrazinamide monoresistance in clinical isolates
, 2013 Aim: To determine pyrazinamide (PZA) monoresistance in clinical isolates of Mycobacterium tuberculosis complex (MTBC) isolated in hospitals in and around ...
ÖZKÜTÜK, NURİ +3 more
core +1 more source
Molecules, 2019 Vibrational modes of pyrazinamide (PZA), 3-hydroxybenzoic acid (3-hBA), and their cocrystal were characterized using terahertz time-domain (THz-TDS) and Raman vibrational spectroscopic techniques.
Qiqi Wang, Jiadan Xue, Zhi Hong, Yong Du
doaj +1 more source
Consistency with Taiwan Guidelines in prescribing Pyrazinamide.
, 2013 Consistency with Taiwan Guidelines in prescribing Pyrazinamide.
Chen-Yuan Chiang (139384) +7 more
core +1 more source
In Silico study of pyrazinamide derivatives in Mycobacterium tuberculosis PanD
, 2020 Recent studies show the coupling of pyrazinoic acid in PanD from Mycobacterium tuberculosis, as the end goal of the pro-drug pyrazinamide. We have coupled pyrazinamide derivatives with PanD by means of docking and molecular dynamics, to evaluate the ...
Christian Aliaga Paucar +3 more
core +1 more source
Final model parameters for rifampicin, isoniazid, and pyrazinamide.
, 2023 Final model parameters for rifampicin, isoniazid, and pyrazinamide.
Helen McIlleron (330065) +13 more
core +1 more source
Molecular Structure of Pyrazinamide: a Critical Assessment of Modern Gas Electron Diffraction Data from Three Laboratories [PDF]
, 2020 Accuracy and precision of molecular parameters determined by modern gas electron diffraction methodhave been investigated. Diffraction patterns of gaseous pyrazinamide have been measured independently in three laboratories, in Bielefeld (Germany ...
Timo, Glodde +4 more
core +1 more source
Inhibition of probenecid uricosuria by pyrazinamide and para-aminohippurate
, 1977 Both para-aminohippurate (PAH) and pyrazinamide inhibited the uricosuric response to probenecid administration. The mechanism of this inhibition of probenecid uricosuria was assessed in 18 male subjects.
H. S. Diamond, A. D. Meisel
core +1 more source